Wednesday, June 10, 2026

pharma Β· Infertility Β· Ovarian Cancer Β· NWBO

NORTHWEST BIOTHERAPEUTICS

NORTHWEST BIOTHERAPEUTICS clinical programs β€” 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO Β· NYSE Ticker
Company details
Status
Public
HQ
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
Founded
1998
Employees
20
Programs
33
Drugs
40
Patents
595
Intelligence Β· Clinical Programs

NORTHWEST BIOTHERAPEUTICS projects

2 ClinicalTrials.gov programs sponsored by NORTHWEST BIOTHERAPEUTICS.

NORTHWEST BIOTHERAPEUTICS has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Ketamine Hydrochloride

    NORTHWEST BIOTHERAPEUTICS INC

    Revision Spine Surgery

    approved small molecule active

    1 trial
  2. Mifepristone

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy Related

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does NORTHWEST BIOTHERAPEUTICS have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.